Mycoplasma pneumoniae Antibody, IgA
Also known as: MYCO A
Use
The Mycoplasma pneumoniae Antibody, IgA test is a semi-quantitative enzyme-linked immunosorbent assay (ELISA) used to detect the presence of IgA antibodies to Mycoplasma pneumoniae in the serum. These antibodies can be indicative of a recent or ongoing infection caused by Mycoplasma pneumoniae, a bacteria responsible for respiratory infections including atypical pneumonia. Detection of IgA antibodies is especially useful in the diagnosis of Mycoplasma pneumoniae infections as IgA is released on mucosal surfaces and is a good marker for current respiratory infections.
Special Instructions
The test is performed by BioAgilytix Diagnostics, which is a CLIA certified and CAP accredited laboratory for performing high complexity assays. Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.
Limitations
The test has not been approved or cleared by the US FDA, but it has been validated for clinical diagnosis by BioAgilytix Diagnostics. The presence of antibodies does not necessarily indicate an active infection; results should be interpreted in the context of a patient's clinical condition.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 13270-4
Result Turnaround Time
7-10 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.6 mL
Container
Plain red or serum separator tube (SST)
Collection Instructions
Transfer 1 mL serum to an ARUP Standard Transport Tube and freeze immediately.
Causes for Rejection
Thawed specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 2 weeks |
| Frozen | 1 month |
Other tests from different labs that may be relevant